How to Document PMHNP Sessions and Split Appointments

Psychiatric-mental health nurse practitioners (PMHNPs) are now the fastest-growing segment of mental health prescribers in the United States. They work across every setting where psychiatric care happens: community mental health centers, private practices, integrated primary care, inpatient units, and telehealth platforms. Many do not just prescribe. They also provide psychotherapy, either in the same appointment as medication management or in separate dedicated sessions.

That dual clinical role creates a documentation problem that most training programs and practice resources do not address directly. A PMHNP who provides therapy and medication management in the same encounter must satisfy two distinct sets of documentation standards simultaneously. A PMHNP who provides them in separate sessions, working alongside a collaborating therapist in a split treatment arrangement, faces a different set of challenges: coordinating records across providers, documenting role boundaries, and ensuring each note reflects what actually happened in each portion of care.

This guide addresses both scenarios in practical terms.

Why PMHNP Documentation Is Different from Either Therapist or Physician Notes

A therapist writing a session note is documenting a therapeutic process. A physician writing a medication management note is documenting a clinical decision and its medical rationale. A PMHNP in active clinical practice often has to do both, and the conventions for each format do not map neatly onto each other.

Therapist notes emphasize client language, relational observations, interventions used, and response to treatment within the session. They typically do not require documentation of medical decision-making complexity.

Physician medication management notes require documented clinical reasoning that justifies the prescription decision, an Evaluation and Management (E/M) level supported by the note itself, and a mental status examination (MSE) that reflects direct observation rather than patient self-report alone.

When a PMHNP provides both in the same visit, neither format alone is sufficient. When they provide them in separate appointments, each note must still meet the documentation standards of its respective service.

The billing layer adds further complexity. PMHNPs may bill independently under their own National Provider Identifier (NPI), or they may bill under a collaborating physician's NPI using incident-to billing rules, which carry their own documentation requirements. The distinction matters because incident-to billing requires the physician to be on site and the treatment plan to have been established by the physician. Each billing pathway changes what needs to appear in the record.

Split Appointments: Understanding the Structure

A split appointment refers to any encounter in which a single visit includes both a psychotherapy component and a medication management component delivered by the same clinician. CMS and most commercial payers recognize this structure through specific CPT add-on codes.

The standard CPT framework for split appointments uses:

• 90833 (16-30 minutes of psychotherapy added to E/M, 30+ minute E/M visit)
• 90836 (16-30 minutes added to E/M, 45+ minute E/M visit)
• 90838 (16-30 minutes added to E/M, 60+ minute E/M visit)

These are add-on codes, meaning they are billed alongside a primary E/M code (99212-99215), not as standalone services. The E/M code covers the medication management component; the add-on covers the psychotherapy component.

What this means for documentation: the note must justify both codes. The E/M portion requires documentation of Medical Decision Making (MDM) complexity or time-based documentation. The psychotherapy add-on requires documentation of the psychotherapy intervention itself, including what was done, what the patient's response was, and how it connects to the treatment plan.

Many PMHNP notes fail this standard not because the clinician did not do the work, but because the note does not show it. Listing "supportive therapy provided" in one line does not document a psychotherapy service. It names a category.

Documenting the E/M Portion: Medical Decision Making for Psychiatric Visits

The Medical Decision Making (MDM) framework under current CPT guidelines has three elements: the number and complexity of problems addressed, the amount and complexity of data reviewed, and the risk of complications or morbidity from treatment.

For psychiatric medication management, here is how each element typically appears in a compliant note:

Problems addressed: Be specific about the diagnostic status and current symptom burden. "Major depressive disorder, recurrent, moderate severity" is more useful than "depression follow-up." If you are addressing more than one condition (for example, MDD with comorbid generalized anxiety disorder), name each one and document the current trajectory of each.

Data reviewed: This includes rating scale scores (PHQ-9, GAD-7, PCL-5, C-SSRS, YMRS), laboratory results if relevant (thyroid panel, lithium level, metabolic panel for antipsychotic monitoring), and any collateral information from the collaborating therapist. Each data source reviewed should appear in the note by name.

Risk: Prescription of psychotropic medications with known side effect profiles, drug-drug interaction considerations, or controlled substance status represents moderate to high risk depending on the specific decisions made. Document the risk-benefit conversation, not just the conclusion.

Example: MDM Documentation for a PMHNP Follow-Up

Patient: D.R., 34-year-old, established patient. Problems: MDD, recurrent episode, currently moderate (PHQ-9: 12, compared to 18 at last visit 4 weeks ago). GAD, moderate; patient reports worry has not responded as well as depression. Active problem count: 2. Data reviewed: PHQ-9 score as above. GAD-7 score: 14 (unchanged from last visit). Pharmacy fill history confirmed adherence to escitalopram 20 mg daily and clonazepam 0.5 mg as needed. No laboratory results pending. Risk: Moderate. Patient is on scheduled benzodiazepine for GAD; discussed risk of dependence and reassessed appropriateness of ongoing PRN use. Patient's use remains infrequent (2-3 times per month by report). No dose change made today. PDMP queried; no concerning fills identified.

This level of documentation supports a 99214 E/M level.

Documenting the Psychotherapy Component in a Split Appointment

The psychotherapy add-on requires documentation of actual psychotherapy work, not just a reference to it. The note should show:

1. What psychotherapeutic approach or technique was used (not just "supportive therapy" but the specific modality or intervention)
2. What the patient's response to the intervention was
3. How the therapy content connects to the treatment goals

Weak documentation: "Supportive therapy provided during appointment. Patient discussed work stressors."

Stronger documentation: "Psychotherapy component (20 minutes): Using Cognitive Behavioral Therapy (CBT) framework, explored the patient's cognitive distortion pattern around work performance. Identified automatic thought: 'If I miss one deadline, I will lose my job.' Collaboratively examined evidence for and against this belief. Patient was able to articulate a more balanced alternative ('One missed deadline has consequences I can manage') with moderate conviction. Assigned between-session worksheet tracking automatic thoughts in work contexts. Response: patient engaged actively; affect brightened during reframing exercise. This addresses treatment plan goal: 'Patient will identify and challenge maladaptive automatic thoughts in work situations.'"

This documents a 90833 add-on appropriately alongside the E/M note.

Time-Based Documentation as an Alternative

For PMHNPs who prefer time-based E/M documentation rather than MDM complexity, the entire visit time must be documented, including how much of that time was devoted to the E/M component versus the psychotherapy component. Because the psychotherapy add-on requires at least 16 minutes of psychotherapy time, the note must support this. A record that says only "45-minute visit" with no time breakdown does not justify both codes.

Document it this way: "Total visit time: 50 minutes. Time devoted to evaluation and management of psychiatric medications: 25 minutes. Time devoted to psychotherapy: 25 minutes."

Split Treatment Documentation: When the Therapist and Prescriber Are Different People

Split treatment in the more common usage refers to a treatment model in which one clinician provides psychotherapy and a different clinician provides psychiatric medication management. The patient sees both providers, often on different days or weeks.

For the PMHNP in this arrangement, the documentation responsibilities are narrower but still require attention to several elements that are often underdocumented.

Documenting Coordination with the Collaborating Therapist

Every medication management note in a split treatment arrangement should include a coordination of care entry, even if brief. This entry should document:

• Whether the PMHNP communicated with the therapist this period (and if so, what was discussed)
• Whether relevant clinical information was shared with the patient's consent
• Any clinical information received from the therapist that informed today's medication decisions

Example coordination entry: "Coordinating with Ms. Elena Reyes, LCSW (patient's therapist): spoke by phone 4/10/2026. Ms. Reyes reports patient has been engaging consistently in weekly sessions and is making progress on CBT skills for anxiety management. Ms. Reyes did not report any safety concerns. This information consistent with patient's self-report today. Patient has signed ROI authorizing communication between providers."

If no communication occurred this period, note that as well: "No direct communication with collaborating therapist since last visit. No safety or clinical concerns communicated by patient requiring emergency contact."

The reason to document absence of communication as well as presence: if a clinical incident occurs and the record only shows coordination entries when contact happened, a retrospective reviewer cannot tell the difference between a period when no coordination occurred and a period when it occurred but was not documented.

Role Clarity in Each Note

When one provider is doing both therapy and medication management on different days, each note type must be clearly labeled and bounded. A medication management note is not the place to process the patient's childhood trauma history in depth. A therapy note is not the place to document a medication change rationale.

This boundary matters beyond just organizational neatness. Psychotherapy notes have heightened protection under HIPAA: a patient can request their general medical record without automatically receiving psychotherapy process notes. If a PMHNP's therapy notes and medication management notes are intermingled in a single undifferentiated document, this protection becomes difficult to maintain.

Each note should be labeled at the top with the service type: "Psychiatric Medication Management Visit" or "Individual Psychotherapy Session." The clinical content that follows should match.

Risk Assessment Documentation During Medication Checks

Risk assessments are often skimped on in medication management notes because the visit is brief and the patient appears stable. This is where documentation gaps create the most exposure.

Every psychiatric medication management visit should include a documented suicide risk assessment, even when risk is low. The documentation does not need to be lengthy, but it must be present.

At minimum, document:

• Ideation: presence or absence of suicidal ideation; if present, whether with intent and/or plan
• Access to means: whether the patient has access to lethal means (firearms, stockpiled medications), particularly relevant in patients on controlled substances
• Current stressors: any acute stressors that might elevate risk
• Protective factors: factors reducing risk (social support, reasons for living, engagement in treatment)
• Clinical determination: your risk level assessment (low, moderate, high) and the clinical reasoning behind it

Example: "C-SSRS administered today. Patient denies current suicidal ideation, intent, or plan. No recent access to firearms reported. Patient reports ongoing support from spouse. Acute stressor identified: layoff notification received this week. Clinical determination: low risk given absence of ideation and strong social support, with heightened monitoring warranted given new acute stressor. Patient instructed to contact office or 988 if ideation emerges. Plan: follow-up in 2 weeks rather than standard 4 weeks given acute stressor."

Note how this entry documents both the absence of immediate risk and the clinical rationale for the safety plan adjustment. An auditor reviewing this note sees evidence of active clinical reasoning, not a rote checkbox.

Medication Reconciliation Documentation

Medication reconciliation at every visit is a patient safety standard, not just a billing requirement. For a PMHNP, the medication reconciliation entry should reflect an active review process.

Document the full current medication list with dose and frequency. Then specifically address:

• Whether the patient has filled and taken medications as prescribed
• Whether any medications were changed by another provider since the last visit (primary care, specialist, urgent care)
• Any over-the-counter medications, herbals, or supplements with potential psychiatric or drug-drug interaction relevance

Practical documentation example: "Medication reconciliation completed with patient today. Patient confirmed current medications: sertraline 100 mg daily (taking consistently), hydroxyzine 25 mg PRN anxiety (used approximately twice weekly by report), vitamin D 2000 IU daily (patient-initiated, reported to PCP). Patient notes PCP started lisinopril 5 mg daily at visit two weeks ago for newly diagnosed hypertension. No known interaction with current psychiatric medications. PCP contact info updated in chart. Patient denies use of cannabis, other supplements, or OTC sleep aids."

This entry supports continuity of care and demonstrates that the prescriber is actively managing the patient's complete pharmacological picture, not just their psychiatric medications in isolation.

Tracking Treatment Response Across Both Modalities

When a patient receives both psychopharmacological and psychotherapeutic treatment, the notes should reflect how each modality is contributing to overall clinical progress. This is particularly important when making medication decisions: if a patient is not improving on a medication, the note should reflect whether therapy adherence, life stressors, or medication nonadherence are confounding the picture.

A longitudinal treatment response table embedded in or referenced from quarterly progress notes is a useful tool. It should show:

This table communicates clinical trajectory in a format that any reviewer, a supervising physician, an insurance auditor, or a new provider covering for you, can interpret at a glance.

Incident-To Billing: What the Documentation Must Show

Incident-to billing allows a PMHNP to bill under a supervising physician's NPI at the physician rate (100% Medicare fee schedule rather than 85%). This is financially significant but carries documentation requirements that many PMHNPs do not fully address.

To bill incident-to, the following conditions must be met and should be documented:

1. The supervising physician must be on-site during the service (not just available by phone). Document this: "Supervising physician [name] present in office suite during this service."
2. The treatment plan must have been established by the physician. The initial plan or a subsequent update must include physician authorship. If a PMHNP saw a patient initially and the physician has never been involved, incident-to billing for that patient is not appropriate.
3. The service must be part of an ongoing treatment plan. New problems or new conditions not addressed in the physician-established plan cannot be billed incident-to.
4. The PMHNP must be an employee or contractor of the supervising physician's practice, not independent.

The consequence of billing incident-to without meeting these requirements is considered Medicare fraud. The documentation burden falls on the PMHNP to demonstrate compliance.

Independent billing, by contrast, requires no physician involvement but pays at 85% of the Medicare fee schedule. The note requirements are identical to what any prescriber would write; the distinction is purely on the billing form.

Fictional Example: Two Documentation Approaches for the Same Visit

Patient: M.V., 42-year-old with bipolar I disorder (F31.13, most recent episode depressed, severe).

Incident-to documentation entry: "Dr. James Calloway, MD, supervising physician, present in suite during this appointment. This visit is a continuation of the treatment plan established by Dr. Calloway at initial evaluation on 01/22/26, in which he initiated lamotrigine titration and established monitoring schedule. Today's visit: lamotrigine 100 mg daily (titration from 75 mg at last visit). Patient tolerating well. No rash. Mood tracking app data reviewed: average mood +2.1/10 over past two weeks, compared to -3.4/10 at baseline. PHQ-9: 9 (down from 21 at baseline). YMRS: 4, no manic symptoms. Assessment: partial response to lamotrigine titration, trajectory positive. Plan: continue lamotrigine 100 mg, reassess at 150 mg in 4 weeks pending continued tolerability."

Independent billing note for the same clinical content would contain the same clinical information but would not include the incident-to language about physician supervision, and would be billed under the PMHNP's own NPI.

Common PMHNP Documentation Mistakes

1. Documenting a split appointment without time breakdown. Writing a combined note without specifying how many minutes were devoted to E/M versus psychotherapy prevents accurate coding of the add-on code.

2. Combining therapy process content with medication management content. When notes are not labeled and separated by service type, psychotherapy note protections may be inadvertently waived and billing compliance becomes difficult to demonstrate.

3. Copying forward medication lists without active reconciliation. Carrying forward a medication list without confirming it at each visit is both a patient safety risk and a documentation compliance failure. A copied list that does not match what the patient is actually taking is inaccurate, not just incomplete.

4. Omitting coordination of care entries in split treatment arrangements. The absence of any coordination documentation in a split treatment model is a red flag in audits and a genuine patient safety gap.

5. Documenting risk assessment as a checkbox rather than a clinical entry. "Denies SI/HI" is not a risk assessment. It is one data point. A defensible risk entry includes ideation, intent, plan, means, stressors, protective factors, and clinical determination.

6. Using incident-to billing without documenting physician presence. This is the most consequential error on this list. If the physician was not on-site or the conditions were not met, incident-to billing is not appropriate regardless of what the note says.

7. Treating the MSE as optional on brief visits. The MSE is the objective section of the note. Without it, the note is entirely based on patient self-report, which is not a sufficient clinical record for prescribing psychotropic medications.

A Full Split Appointment Note Example (SOAP Format)

Patient: R.L., 29-year-old, established patient. Diagnoses: MDD, recurrent, moderate (F33.1); GAD (F41.1). Billing: 99214 + 90833 (independent billing, PMHNP NPI) Visit time: 50 minutes. E/M: 25 minutes. Psychotherapy: 25 minutes.

---

S (Subjective): Patient presents for combined medication management and psychotherapy appointment. Interval history: patient reports significant improvement in sleep over past 3 weeks since sertraline dose increase to 150 mg (now consistently achieving 7 hours vs. 5 hours previously). Morning energy improved. Persistent moderate anxiety around upcoming performance review at work. PHQ-9: 9 (down from 16 at last visit). GAD-7: 12 (compared to 14 at last visit, modest improvement). Reports taking sertraline 150 mg daily consistently. Denies missed doses. No new medications started by other providers.

O (Objective): Appearance: casually dressed, appropriate hygiene. Behavior: cooperative, good eye contact, no psychomotor abnormalities. Speech: normal rate and rhythm. Mood: "a lot better, but still anxious about work." Affect: brighter than prior visit, congruent with stated mood. Thought process: linear and goal-directed. Thought content: no suicidal ideation, no homicidal ideation, no psychotic symptoms. Insight: good. Judgment: intact. Orientation: A&Ox4. Medication reconciliation: sertraline 150 mg daily confirmed. No new OTC or supplement additions per patient report. Pharmacy fill history reviewed; consistent fills confirmed. Risk screen (C-SSRS): no current ideation, no plan, no intent. Access to means: no firearms at home. Acute stressor: performance review next week. Protective factors: strong partner support, high engagement in treatment, valued employment. Risk determination: low.

A (Assessment):

1. MDD, recurrent, moderate: meaningful response to sertraline dose increase. PHQ-9 trajectory (18 → 16 → 9) consistent with partial-to-strong response. Not yet in remission. Continue current medication.
2. GAD, moderate: partial response. PHQ-9 improvement not fully mirrored by GAD-7 trajectory. Considering addition of buspirone at next visit if anxiety does not continue to improve with ongoing CBT work.
3. Data complexity: moderate (rating scales, pharmacy fill review). Risk: moderate (established patient, psychotropic medications, no acute safety concerns but active acute stressor). MDM level: moderate, supporting 99214.

P (Plan): Medication: continue sertraline 150 mg daily. No changes today. Will reassess buspirone addition at next visit if GAD-7 does not improve. Psychotherapy (25 minutes, CBT framework): focused session on anticipatory anxiety related to performance review. Identified catastrophizing pattern: patient articulated worst-case scenario (job loss) as "almost certain." Used probability estimation technique; patient recalculated realistic probability of termination as "maybe 10%" versus initial estimate of "70%." Patient reported subjective anxiety decrease from 8/10 to 4/10 during exercise. Assigned between-session practice: daily 5-minute worst-case/best-case/realistic-case journaling for work situations. Safety plan: patient instructed to contact office or 988 if anxiety escalates or any SI emerges before next appointment. Coordination: no direct contact with collaborating therapist Ms. Reyes this period. No safety concerns flagged by patient requiring emergency contact. Follow-up: 4 weeks for combined appointment.

---

This note supports the 99214 level through documented MDM complexity and supports the 90833 add-on through a specific psychotherapy intervention with named technique, patient response, and treatment plan linkage.

Checklist: PMHNP Session and Split Appointment Documentation

Every Medication Management Encounter

• Chief complaint and interval history with specific symptom changes (not "doing well")
• Standardized rating scale score with comparison to prior score
• Full medication reconciliation (confirmed with patient, not carried forward)
• MSE with all standard domains completed
• Suicide risk assessment with ideation, intent, plan, means, stressors, protective factors, and clinical determination
• Assessment with diagnostic specificity and treatment response language
• Plan with clinical rationale for continuation, change, or addition

Split Appointment Add-On Documentation

• Total visit time documented
• Time devoted to E/M clearly separated from time devoted to psychotherapy
• Psychotherapy modality and specific technique named (not just "supportive therapy")
• Patient response to psychotherapy intervention documented
• Connection to treatment plan goal established

Split Treatment Arrangement (Different Providers)

• Note labeled as "Medication Management Visit" or "Psychotherapy Session"
• Coordination of care entry present (contact occurred or did not occur, both noted)
• ROI confirming authorization for inter-provider communication referenced
• Clinical information received from therapist documented if relevant to today's decisions

Incident-To Billing

• Supervising physician identified by name and confirmed on-site
• Reference to physician-established treatment plan present
• Service is continuation of existing plan, not a new problem
• PMHNP employment/contractor relationship with physician practice confirmed in practice records

Controlled Substances and High-Risk Medications

• PDMP query documented with outcome
• Risk-benefit conversation documented for scheduled medications
• AIMS administered and documented if patient is on antipsychotics (minimum annually)
• Lithium or valproate levels documented if applicable

---

For PMHNPs managing high note volumes across split appointments and medication management visits, using a structured template that pre-populates the required sections by visit type can reduce documentation time without reducing documentation quality. NotuDocs allows PMHNPs to build and reuse visit-type templates (new intake, med check follow-up, split appointment) so the structure is consistent every time. NotuDocs is not HIPAA compliant and cannot sign a BAA, so it is most appropriate for practitioners whose workflow does not require that layer of compliance.

Related Guides

• How to Document Psychiatric Medication Management Visits and Prescriber Notes
• How to Document Psychiatric Medication Management Sessions (High-Volume Guide)
• How to Document Therapy Sessions Using Standardized Outcome Measures
• What Insurance Auditors Look for in AI-Generated Therapy Notes